Status | Study |
Active, not recruiting |
Study Name: The Phase IVb of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Children Condition: Hand, Foot and Mouth Disease (HFMD) Date: 2016-09-17 Interventions: Biological: inactivated EV71 vaccine (KMB-17 cells) 3.0 EU of inactivated enterovirus 71 vaccine (KMB-17 |
Not yet recruiting |
Study Name: Safety, Three Batches Consistency and Immunity Duration of the Post-marketing Inactivated Enterovirus Type 71 (EV71) Vaccine in Children Aged 6-71 Months Condition: Hand Foot and Mouth Disease Date: 2016-08-31 Interventions: Biological: the first batch vaccine Biolog |
Recruiting |
Study Name: Phase I Study of Intratumoral CAVATAK™ and Pembrolizumab in Subjects With Advanced Melanoma Condition: Melanoma Date: 2015-09-30 Interventions: Biological: CAVATAK Maximum do |
Recruiting |
Study Name: Effect of Xiaoer Jiebiao Oral Liquid on Hand-foot-mouth Disease Condition: Handfoot-mouth Disease Date: 2014-12-18 Interventions: Drug: Ribavirin plus Xiao'er jiebiao oral liquid |
Completed |
Study Name: Safety and Clinical Activity of CAVATAK™ Alone or With Low Dose Mitomycin C in Non-muscle Invasive Bladder Cancer Condition: Non-muscle Invasive Bladder Cancer Date: 2014-12-07 Interventions: Biological: CAVATAK CAVATAK is |
Recruiting |
Study Name: Study of Intratumoral CAVATAK™ (Coxsackievirus A21) and Ipilimumab in Patients With Advanced Melanoma Condition: Melanoma Date: 2014-11-26 Interventions: Biological: CAVATAK CAVATAK is |
Completed |
Study Name: Neurodevelopment Outcomes Following Severe Hand Foot and Mouth Disease in Vietnam Condition: Hand Foot and Mouth Disease Date: 2014-02-14 |
Recruiting |
Study Name: Systemic Treatment Of Resistant Metastatic Disease Employing CVA21 and Pembrolizumab in Non-small Cell Lung Cancer and Bladder Cancer (STORM/ KEYNOTE-200) Condition: Non-small Cell Lung Cancer Bladder Cancer Date: 2014-01-19 Interventions: Biological: CVA21 |
Completed |
Study Name: A Follow-up Study for a Phase III, Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine Condition: Hand, Foot and Mouth Disease Date: 2013-11-27 Interventions: Biological: EV71 vaccine inactivated vaccine (vero cell) against EV71 of 400U /0.5ml, two doses, 28 days |
Completed |
Study Name: Magnesium Sulphate for Severe Hand, Foot and Mouth Disease in Vietnam Condition: Hand, Foot and Mouth Disease Date: 2013-08-22 Interventions: Drug: Magnesium Sulphate MgSO4 |